Rezolute to participate in upcoming investor conferences

Redwood city, calif., may 01, 2025 (globe newswire) -- rezolute, inc. (nasdaq: rzlt) (“rezolute” or the “company”), a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism, today announced that management will participate in the following investor conferences:

RZLT Ratings Summary

RZLT Quant Ranking